91.05SEK-0.82%Mkt Cap: 1.18B $P/E: —Today
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap1.18B $
Enterprise Value1.26B $
Revenue (TTM)324.26M $
Gross Profit191.02M $
Net Income (TTM)-479.41M $
Revenue/Share2.394 USD
Last Price91.05 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.1K
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0011205202
Valuation
P/E (Trailing)—
P/E (Forward)18.74
PEG2.02
EV/EBITDA13.37
EV/Revenue3.90
P/S3.60
P/B1.50
EPS (TTM)-36.80
EPS (Forward)4.81
52W Range
84.0010% of range153.50
52W High153.50 SEK
52W Low84.00 SEK
Profitability
Gross Margin58.05%
Oper. Margin23.10%
EBITDA Margin29.14%
Profit Margin-145.70%
ROE-63.49%
ROA-45.06%
Growth
Revenue Growth-1.60%
Earnings Growth28.70%
Cash Flow & Leverage
Operating CF60.74M $
CapEx (TTM)23.63M $
FCF Margin16.31%
FCF Yield4.48%
Net Debt74.42M $
Net Debt/EBITDA0.79
Balance Sheet
Debt/Equity0.20
Current Ratio3.64
Quick Ratio2.76
Book Value/Sh60.04 SEK
Cash/Share6.077 SEK
Dividends
Fwd Div Rate1.100 SEK
Trail. Div Rate1.100 SEK
Div. Yield1.20%
5Y Avg Yield0.54%
Payout Ratio33.85%
Ex-Div DateMay 6, 2026
Pay Date—
Splits
Last Split5:1
Split DateMay 17, 2018
Analyst Consensus
Rating—
Target (Mean)129.60 SEK
Upside (mean)+42.3%
Target Range95.00 SEK – 155.00 SEK
SEK95.00+42.3% to meanSEK155.00
# Analysts5
Ownership
Shares Out.135.45M
Float73.71M
Insiders29.72%
Institutions57.64%
Technical
SMA 5089.50 (+1.7%)
SMA 200106.80 (-14.7%)
Beta1.71
S&P 52W Chg18.16%
Avg Vol (30d)246.55K
Avg Vol (10d)339.82K
Technical Indicators
RSI (14)56.3
MACD0.1862
MACD Signal-0.2527
MACD Hist.+0.4389
BB Upper92.47 SEK
BB Middle88.37 SEK
BB Lower84.27 SEK
BB Width9.27%
ATR (14)2.795 SEK
Vol Ratio (20d)0.54x